.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Daiichi Sankyo
Dow
Covington
Merck
Queensland Health
Accenture
QuintilesIMS
Moodys
Argus Health

Generated: December 16, 2017

DrugPatentWatch Database Preview

Patents Expiring in September 2020

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Novartis Pharms CorpTYKERBlapatinib ditosylateTABLET;ORAL022059-001Mar 13, 2007RXYesYes► Subscribe► SubscribeYYTREATMENT OF PATIENTS WITH ADVANCED OR METASTATIC BREAST CANCER WHOSE TUMORS OVEREXPRESS HER2 AND WHO HAVE RECEIVED PRIOR THERAPY INCLUDING ANTHRACYCLINE, A TAXANE AND TRASTUZUMAB
Novartis Pharms CorpTYKERBlapatinib ditosylateTABLET;ORAL022059-001Mar 13, 2007RXYesYes► Subscribe► SubscribeYYTREATMENT OF PATIENTS WITH BREAST CANCER WHOSE TUMORS OVEREXPRESS THE HER2 RECEPTOR
Talon TherapMARQIBO KITvincristine sulfateINJECTABLE, LIPOSOMAL;INTRAVENOUS202497-001Aug 9, 2012RXYesYes► Subscribe► SubscribeY
AbbvieTRICORfenofibrateTABLET;ORAL021656-002Nov 5, 2004ABRXYesYes► Subscribe► SubscribeYADJUNCTIVE THERAPY TO DIET IN ADULTS TO REDUCE LDL-C, TOTAL-C, TRIGLYCERIDES AND APO B, AND INCREASE HDL-C IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA OR MIXED DYSLIPIDEMIA (TYPES IIA, IIB) AND TO TREAT HYPERTRIGLYCERIDEMIA (TYPES IV, V)
AbbvieTRICORfenofibrateTABLET;ORAL021656-001Nov 5, 2004ABRXYesNo► Subscribe► SubscribeYADJUNCTIVE THERAPY TO DIET IN ADULTS TO REDUCE LDL-C, TOTAL-C, TRIGLYCERIDES AND APO B, AND INCREASE HDL-C IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA OR MIXED DYSLIPIDEMIA (TYPES IIA, IIB) AND TO TREAT HYPERTRIGLYCERIDEMIA (TYPES IV, V)
Endo Pharms IncMEGACE ESmegestrol acetateSUSPENSION;ORAL021778-001Jul 5, 2005ABRXYesYes► Subscribe► SubscribeY
Portola Pharms IncBEVYXXAbetrixabanCAPSULE;ORAL208383-002Jun 23, 2017RXYesYes► Subscribe► SubscribeYY
Portola Pharms IncBEVYXXAbetrixabanCAPSULE;ORAL208383-001Jun 23, 2017RXYesNo► Subscribe► SubscribeYYPROPHYLAXIS OF DEEP VEIN THROMBOSIS (DVT)
Portola Pharms IncBEVYXXAbetrixabanCAPSULE;ORAL208383-001Jun 23, 2017RXYesNo► Subscribe► SubscribeYYPROPHYLAXIS OF PULMONARY EMBOLISM
Portola Pharms IncBEVYXXAbetrixabanCAPSULE;ORAL208383-001Jun 23, 2017RXYesNo► Subscribe► SubscribeYY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Deloitte
Moodys
McKinsey
QuintilesIMS
Novartis
UBS
Queensland Health
Chinese Patent Office
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot